Neutralising antibodies to the beta interferons

Journal of Neurology Neurosurgery and Psychiatry

Volumn 73, Issue 2, 2002, Pages 110-111

  Coles, A J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; INTERFERON BETA SERINE; NEUTRALIZING ANTIBODY; RECOMBINANT BLOOD CLOTTING FACTOR 8;

BIOASSAY; DISEASE ACTIVITY; ENCEPHALOMYOCARDITIS VIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; GLYCOSYLATION; IMMUNE SYSTEM; IMMUNOADSORBENT; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SHORT SURVEY; VIRUS INHIBITION;

ANTIBODIES; CROSS REACTIONS; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; NEUTRALIZATION TESTS;

EID: 0036328818     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.73.2.110     Document Type: Short Survey

References (5)

1. Neutralizing antibodies during treatment of multiple sclerosis with interferon beta-1b: Experience during the first three years
2. PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS
3. Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: Results of a 2-year prospective randomised multicentre study (INCOMIN)
4. Differential effects of three interferon betas on neutralising antibodies in multiple sclerosis patients: A follow up study in an independent laboratory
5. Immunogenicity of interferon-beta in multiple sclerosis patients: Influence of preparation, dosage, dose frequency, and route of administration